TRIDENT LIFELINE
Back to All Ratios
|
TRIDENT LIFELINE Last 5 Year Total Debt/Mcap History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | |
---|---|---|---|
Total Debt/Mcap(x) | 0.10 | 0.04 | - |
What is the latest Total Debt/Mcap ratio of TRIDENT LIFELINE ?
Year | Total Debt/Mcap |
---|---|
Mar2024 | 0.10 |
Mar2023 | 0.04 |
Mar2022 | - |
How is Total Debt/Mcap of TRIDENT LIFELINE Trending?
Years | Total Debt/Mcap | % Change | |
---|---|---|---|
Mar2024 | 0.1 | 150.00 | |
Mar2023 | 0.04 | 0 | |
Mar2022 | 0 | - |
Other Financial Ratios of TRIDENT LIFELINE
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover |
Compare Total Debt/Mcap ratio of peers of TRIDENT LIFELINE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
TRIDENT LIFELINE | ₹326.0 Cr | 4.1% | 4.1% | 74% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹397,498.0 Cr | 1.9% | -2.1% | -6.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹165,838.0 Cr | 2.7% | -5.6% | 25.2% | Stock Analytics | |
CIPLA | ₹129,330.0 Cr | 3.4% | 7.7% | 0.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹124,235.0 Cr | 0.6% | 4.4% | 9.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹107,211.0 Cr | 3.2% | 1.6% | -8.4% | Stock Analytics |
TRIDENT LIFELINE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
TRIDENT LIFELINE | 4.1% |
4.1% |
74% |
SENSEX | 0.5% |
-1.3% |
0.9% |
You may also like the below Video Courses